Intervention

EVG

ClinicalTrials.gov intervention label

Clinical trials2

Recruiting0

Common conditions2

Lead sponsors shown1

Clinical trials

2 shown

Two Part Study to Evaluate Pharmacokinetics, Safety, and Antiviral Activity of Elvitegravir Administered With a PI/r Background Regimen for ARV Treatment-Experienced Pediatric ParticipantsNCT01923311 · 2013-08-26

Safety of EVG+RTV Administered With Other Antiretroviral Agents for the Treatment of HIV-1 InfectionNCT00445146 · 2007-02-01

Common conditions

HIV Infections2 Acquired Immune Deficiency Syndrome (AIDS)1

Leading sponsors

Gilead Sciences2

Trial status mix

COMPLETED1

TERMINATED1

Phase mix

PHASE22

PHASE31

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.